Skip to content

Effectiveness of a mobile application based management in patients with diabetes.

A study to evaluate the effectiveness of Smart Glucose Manager, a mobile application in the management of diabetes mellitus.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
SLCTR
Registry ID
SLCTR/2017/005
Enrollment
Unknown
Registered
2017-03-10
Start date
2017-03-16
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus

Interventions

The study includes patients registered at outpatient diabetes clinics at General Hospital, Sri Jayewardenepura. Participants will be allocated into the study arms using simple randomization. Recruit

Sponsors

Department of Medicine, Faculty of Medicine, University of Kelaniya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients comply with following criteria will be recruited 1. A diagnosis of diabetes (Type 1, Type 2 or unspecified). 2. Age 18-80. 3. HbA1c above 8%. 4. Having fluctuations in blood glucose (standard deviation 60 mg/ dl and above). 5. Duration of diabetes over one year. 6. Must own a mobile device that supports Android or iOS (iPhone Operating System) applications. 7. Agreed with study protocol and able to give a written consent for the study.

Exclusion criteria

Exclusion criteria: 1. Pregnancy 2. Patients on haemodialysis 3. Steroid induced diabetes 4. Inability to be compliant with the study protocol 5. Presence of cognitive impairment

Design outcomes

Primary

MeasureTime frame
Effectiveness of the smart phone-based diabetes management application, SGM on overall control of diabetes mellitus 1.1. Improvement of glycaemic control as determined by HbA1c. 1.2. Number of harmful blood glucose fluctuations according to pre-determined criteria using a questionnaire [At baseline and every 12 weeks for a total of 52 weeks.]

Secondary

MeasureTime frame
Effect of SGM on blood glucose levels, lipid profile and occurrence and progression of complications such as dyslipidemia, nephropathy, neuropathy, and micro-vascular complications by following biochemical and physical investigations. 1 Lipid panel (Cholesterol, HDL Cholesterol, LDL Cholesterol, Triglycerides) 2 Fasting blood glucose. 3 Comprehensive Metabolic panel (Alkaline phosphatase, ALT, AST, Blood urea nitrogen, Potassium, Sodium, Calcium, Chloride, Creatinine, Albumin, Total protein). 4 Urine for micro albumin. 5 Foot examination. • Clinical examination by a medical officer/ nursing officer trained in podiatry (inspect for foot ulcers, callus formation, fungal infection) • Monofilament testing for peripheral sensation. • Ankle Brachial Pressure Index measurement with the Doppler device 6 Dilated eye examination [At baseline and every 12 weeks for a total of 52 weeks.]

Countries

Sri Lanka

Contacts

Public ContactDr. Shaluka Jayamanne

Consultant Physician, Senior Lecturer in Medicine

shalukajaya@yahoo.comTel:0112961119

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 9, 2026